Everett Vokes
Section of Hematology / Oncology
Professor of Medicine
John E. Ultmann Professor;Chair,Department of Medicine;Physician-in-Chief,University of Chicago Medicine

Training

DegreeYearInstitutionArea
BA1973Paul Schneider GymnasiumPre-med
MD1980University of Bonn 
Residency1982Ravenswood HospitalInternal Medicine
Residency1983University of Southern California Internal Medicine
Fellowship1986The University of ChicagoHematology/Oncology

Academic Interests

Dr. Vokes is an internationally renowned expert in the treatment of head and neck and lung cancer. He is an accomplished clinical and translational investigator who has brought together clinical and scientific multimodality teams to address complex solid tumors leading to improved treatment outcomes. He is known for his work in the biology and treatment of lung and head and neck cancer and the interaction of chemotherapy and radiation. His work on concomitant chemoradiation has contributed to increased cure rates and spared many patients from radical surgery. He also established the intellectual and clinical basis of national trials investigating concomitant chemoradiotherapy and other approaches to curative intent multispecialty care.


Clinical Interests

Head and neck cancer and lung cancer


Representative Publications

  1. Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington K, Kasper S, Vokes EE, Even C, Worden F, Saba NF, Iglesias Docampo LC, Haddad R, Rordorf T, Kiyota N, Tahara M, Monga M, Lynch M, Geese WJ, Kopit J, Shaw JW, Gillison ML. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.N Engl J Med. 2016 Nov 10;375(19):1856-1867.
  2. Seiwert TY, Zuo Z, Keck MK, Khattri A, Pedamallu CS, Stricker T, Brown C, Pugh TJ, Stojanov P,Cho J, Lawrence MS, Getz G, Bragelmann J, DeBoer R, Weichselbaum RR, Langerman A Portugal L, Blair E, Stenson K, Lingen MW, Cohen EW, Vokes EE, White KP, Hammerman PS. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin Cancer Res, 21(3): 632-41, 2015.
  3. Vokes EE, Agrawal N, Seiwert TY. HPV-Associated Head and Neck Cancer.J Natl Cancer Inst. 2015 Dec 9;107(12).
  4. Seiwert TY, Zuo Z, Keck MK, Khattri A, Pedamallu CS, Stricker T, Brown C, Pugh TJ, Stojanov P,Cho J, Lawrence MS, Getz G, Bragelmann J, DeBoer R, Weichselbaum RR, Langerman A Portugal L, Blair E, Stenson K, Lingen MW, Cohen EW, Vokes EE, White KP, Hammerman PS. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin Cancer Res, 21(3): 632-41, 2015.
  5. Seiwert TY, Melotek JM, Blair EA, Stenson KM, Salama JK, Witt ME, Brisson RJ, Chawla A, Dekker A, Lingen MW, Kocherginsky M, Villaflor VM, Cohen EE, Haraf DJ, Vokes EE.Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):21-9.



More Information

For more information about Dr. Everett Vokes publications and research collaborations , please click here